Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

The uveitis clinical trial market research report provides an overview of the uveitis clinical trials scenario. The report provides top-line data relating to the clinical trials on uveitis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.

Uveitis Clinical Trials Market Segmentation by Regions and Countries

The key regions in the uveitis clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America.

In a country-wise analysis, as of November 2022, the UK has the highest number of uveitis clinical trials, followed by Germany, the UK, China, France, India, Spain, Japan, Italy, and Israel. 

G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the UK has the highest proportion of uveitis to ophthalmology clinical trials. Moreover, out of all the clinical trials conducted in the G7 countries, the majority were in the US.

E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Indonesia has the highest proportion of uveitis to ophthalmology clinical trials. Out of all the clinical trials conducted in the E7 countries, the majority were in China.  

Uveitis Clinical Trials Analysis by Regions

For more regional insights into the uveitis clinical trials market, download a free report sample

Uveitis Clinical Trials Market Segmentation by Sponsor Types

The key sponsor types in the uveitis clinical trials market are institution, company, and the government. Out of them, company dominates the market.

Uveitis Clinical Trials Market Analysis by Sponsor Types

For more sponsor type insights into the uveitis clinical trials market, download a free report sample

Uveitis Clinical Trials Market - Competitive Landscape

The leading sponsors in the uveitis clinical trials market are Novartis AG, AbbVie Inc, EyePoint Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd, Bausch Health Companies Inc, IQVIA Holdings Inc, XOMA Corp, Alcon Inc, Clearside BioMedical Inc, and Les Laboratoires Servier SAS. Out of them, Novartis AG has conducted the highest number of uveitis clinical trials. 

Uveitis Clinical Trials Market Analysis by Sponsors

To know more about the leading players in the uveitis clinical trials market, download a free report sample

Uveitis Clinical Trials Market Report Overview

Scope

• The report provides a snapshot of the global clinical trials landscape
• The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status
• The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
• The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for unaccomplishment
• The report provides enrollment trends for the past five years
• The report provides the latest news for the past three months

Reasons to Buy

• Assists in formulating key business strategies concerning investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in the global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional, and country level